507 related articles for article (PubMed ID: 25385097)
21. Mutant prevention concentrations for single-step fluoroquinolone-resistant mutants of wild-type, efflux-positive, or ParC or GyrA mutation-containing Streptococcus pneumoniae isolates.
Smith HJ; Walters M; Hisanaga T; Zhanel GG; Hoban DJ
Antimicrob Agents Chemother; 2004 Oct; 48(10):3954-8. PubMed ID: 15388458
[TBL] [Abstract][Full Text] [Related]
22. Quinolone-resistant Haemophilus influenzae: determination of mutant selection window for ciprofloxacin, garenoxacin, levofloxacin, and moxifloxacin.
Li X; Mariano N; Rahal JJ; Urban CM; Drlica K
Antimicrob Agents Chemother; 2004 Nov; 48(11):4460-2. PubMed ID: 15504883
[TBL] [Abstract][Full Text] [Related]
23. Role of type II topoisomerase mutations and AcrAB efflux pump in fluoroquinolone-resistant clinical isolates of Proteus mirabilis.
Saito R; Sato K; Kumita W; Inami N; Nishiyama H; Okamura N; Moriya K; Koike K
J Antimicrob Chemother; 2006 Sep; 58(3):673-7. PubMed ID: 16870650
[TBL] [Abstract][Full Text] [Related]
24. The acquisition of full fluoroquinolone resistance in Salmonella Typhi by accumulation of point mutations in the topoisomerase targets.
Turner AK; Nair S; Wain J
J Antimicrob Chemother; 2006 Oct; 58(4):733-40. PubMed ID: 16895934
[TBL] [Abstract][Full Text] [Related]
25. Emergence of Haemophilus influenzae with low susceptibility to quinolones and persistence in tosufloxacin treatment.
Tanaka E; Hara N; Wajima T; Ochiai S; Seyama S; Shirai A; Shibata M; Shiro H; Natsume Y; Noguchi N
J Glob Antimicrob Resist; 2019 Sep; 18():104-108. PubMed ID: 30753907
[TBL] [Abstract][Full Text] [Related]
26. Update on fluoroquinolone resistance in Helicobacter pylori: new mutations leading to resistance and first description of a gyrA polymorphism associated with hypersusceptibility.
Cattoir V; Nectoux J; Lascols C; Deforges L; Delchier JC; Megraud F; Soussy CJ; Cambau E
Int J Antimicrob Agents; 2007 Apr; 29(4):389-96. PubMed ID: 17303392
[TBL] [Abstract][Full Text] [Related]
27. Observation of a new pattern of mutations in
Dasgupta N; Paul D; Chanda DD; Chetri S; Chakravarty A; Bhattacharjee A
Indian J Med Microbiol; 2018; 36(1):131-135. PubMed ID: 29735844
[TBL] [Abstract][Full Text] [Related]
28. Occurrence of fluoroquinolones and fluoroquinolone-resistance genes in the aquatic environment.
Adachi F; Yamamoto A; Takakura K; Kawahara R
Sci Total Environ; 2013 Feb; 444():508-14. PubMed ID: 23291652
[TBL] [Abstract][Full Text] [Related]
29. Emergence of a fluoroquinolone-resistant strain of Streptococcus pneumoniae in England.
Johnson AP; Sheppard CL; Harnett SJ; Birtles A; Harrison TG; Brenwald NP; Gill MJ; Walker RA; Livermore DM; George RC
J Antimicrob Chemother; 2003 Dec; 52(6):953-60. PubMed ID: 14585858
[TBL] [Abstract][Full Text] [Related]
30. In vitro activities of garenoxacin (BMS-284756) against Haemophilus influenzae isolates with different fluoroquinolone susceptibilities.
Pérez-Vázquez M; Román F; Aracil B; Cantón R; Campos J
Antimicrob Agents Chemother; 2003 Nov; 47(11):3539-41. PubMed ID: 14576114
[TBL] [Abstract][Full Text] [Related]
31. In vitro activity of sitafloxacin against clinical strains of Streptococcus pneumoniae with defined amino acid substitutions in QRDRs of gyrase A and topoisomerase IV.
Touyama M; Higa F; Nakasone C; Shinzato T; Akamine M; Haranaga S; Tateyama M; Nakasone I; Yamane N; Fujita J
J Antimicrob Chemother; 2006 Dec; 58(6):1279-82. PubMed ID: 17056610
[TBL] [Abstract][Full Text] [Related]
32. Increase in fluoroquinolone non-susceptibility among clinical Streptococcus pyogenes in Belgium during 2007-10.
Van Heirstraeten L; Leten G; Lammens C; Goossens H; Malhotra-Kumar S
J Antimicrob Chemother; 2012 Nov; 67(11):2602-5. PubMed ID: 22815354
[TBL] [Abstract][Full Text] [Related]
33. Fluoroquinolone-resistant Haemophilus influenzae: frequency of occurrence and analysis of confirmed strains in the SENTRY antimicrobial surveillance program (North and Latin America).
Biedenbach DJ; Jones RN
Diagn Microbiol Infect Dis; 2000 Apr; 36(4):255-9. PubMed ID: 10764968
[TBL] [Abstract][Full Text] [Related]
34. Clinical characteristics in adult patients with Salmonella bacteremia and analysis of ciprofloxacin-nonsusceptible isolates.
Cheng MW; Lee CM; Wang NY; Wu AY; Lin CC; Weng LC; Liu CP; Shih SC
J Microbiol Immunol Infect; 2015 Dec; 48(6):692-8. PubMed ID: 26542649
[TBL] [Abstract][Full Text] [Related]
35. Fluoroquinolone resistance mechanism of clinical isolates and selected mutants of Pasteurella multocida from bovine respiratory disease in China.
Kong LC; Gao D; Gao YH; Liu SM; Ma HX
J Vet Med Sci; 2014 Dec; 76(12):1655-7. PubMed ID: 25649952
[TBL] [Abstract][Full Text] [Related]
36.
Honda H; Sato T; Shinagawa M; Fukushima Y; Nakajima C; Suzuki Y; Kuronuma K; Takahashi S; Takahashi H; Yokota SI
Antimicrob Agents Chemother; 2020 Jan; 64(2):. PubMed ID: 31740553
[No Abstract] [Full Text] [Related]
37. Molecular mechanisms of decreased susceptibility to fluoroquinolones in avian Salmonella serovars and their mutants selected during the determination of mutant prevention concentrations.
Kehrenberg C; de Jong A; Friederichs S; Cloeckaert A; Schwarz S
J Antimicrob Chemother; 2007 May; 59(5):886-92. PubMed ID: 17369276
[TBL] [Abstract][Full Text] [Related]
38. Emergence and properties of fluoroquinolone resistant Salmonella enterica serovar Typhi strains isolated from Nepal in 2002 and 2003.
Nobthai P; Serichantalergs O; Wongstitwilairoong B; Srijan A; Bodhidatta L; Malla S; Mason CJ
Southeast Asian J Trop Med Public Health; 2010 Nov; 41(6):1416-22. PubMed ID: 21329318
[TBL] [Abstract][Full Text] [Related]
39. Rise in Haemophilus influenzae With Reduced Quinolone Susceptibility and Development of a Simple Screening Method.
Seyama S; Wajima T; Yanagisawa Y; Nakaminami H; Ushio M; Fujii T; Noguchi N
Pediatr Infect Dis J; 2017 Mar; 36(3):263-266. PubMed ID: 27870809
[TBL] [Abstract][Full Text] [Related]
40. Increasing resistance to fluoroquinolones among Haemophilus species in Southern Taiwan.
Chang CM; Tang HJ; Wang LR; Shih HI; Huang CC; Lee NY; Lee CC; Ko WC
J Microbiol Immunol Infect; 2017 Apr; 50(2):258-260. PubMed ID: 27289531
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]